Mind the Byte

Mind the Byte offers a pay-per-use SaaS platform with latest generation software

Startup

ABOUT MIND THE BYTE

      
Computational drug discovery can reduce development time and costs for new drugs by up to 30%, and in 2016 it is expected to represent 20% of total global RD&I expenditure in pharma companies.
 
Mind the Byte offers a pay-per-use SaaS platform (software as a service) with latest generation software (Cabrakan, Hurakan and Ixchel) that, starting from a molecule (SDF or SMILE file), allows users to predict which proteins it will interact with as well as its therapeutic indications in only minutes.

This platform was developed by Mind the Byte to break through the most important technological and economic barriers of computational design for companies and research centres
    

PROFILE STRENGTH

BEGINNER
ADVANCED
REAL PRO

NEWS

Recently added news from Mind the Byte:
Equity Crowdfunding para una startup de bioinformática

This website uses cookies to allow us to see how the site is used. If you continue to use this site we will assume that you are happy with this. If you want to use the site without cookies or would like to know more, you can do that. here .